The interplay between myeloma cells and the microenvironment (bone marrow stromal cells, osteoblasts, osteoclasts, and osteocytes) is crucial in promoting tumor survival as well as bone lesions. Novel therapeutic approaches targeting this interplay are shown in the Figure.